Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Adipocyte-derived endotrophin promotes malignant tumor progression.

Park J, Scherer PE.

J Clin Invest. 2012 Nov;122(11):4243-56. doi: 10.1172/JCI63930.

2.

Endotrophin in the tumor stroma: a new therapeutic target for breast cancer?

Park J, Scherer PE.

Expert Rev Anticancer Ther. 2013 Feb;13(2):111-3. doi: 10.1586/era.12.164. Review. No abstract available.

3.

Collagen VI and hyaluronan: the common role in breast cancer.

Karousou E, D'Angelo ML, Kouvidi K, Vigetti D, Viola M, Nikitovic D, De Luca G, Passi A.

Biomed Res Int. 2014;2014:606458. doi: 10.1155/2014/606458. Review.

4.

Collagen VI in cancer and its biological mechanisms.

Chen P, Cescon M, Bonaldo P.

Trends Mol Med. 2013 Jul;19(7):410-7. doi: 10.1016/j.molmed.2013.04.001. Review.

PMID:
23639582
5.

The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Taylor MA, Parvani JG, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. doi: 10.1007/s10911-010-9181-1. Review.

6.

Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy.

Zins K, Sioud M, Aharinejad S, Lucas T, Abraham D.

Methods Mol Biol. 2015;1218:143-61. doi: 10.1007/978-1-4939-1538-5_9. Review.

PMID:
25319650
7.

Target validation using RNA interference in solid tumors.

Aharinejad S, Sioud M, Lucas T, Abraham D.

Methods Mol Biol. 2007;361:227-38. Review.

PMID:
17172715
8.

[Hypoxia as the main activator of angiogenesis and fatty tissue growth].

Kalinina NI, Efimenko AIu, Starostina EE, Parfenova EV, Tkachuk VA.

Ross Fiziol Zh Im I M Sechenova. 2009 Mar;95(3):283-9. Review. Russian.

PMID:
19449784
Items per page

Supplemental Content

Support Center